Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Molecular and Clinical Oncology
|
October 16, 2020
Erratum: Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
Yasuyoshi Miyata, Kyohei Araki, Kojiro Ohba, et al.
Cancer Diagnosis & Prognosis
|
May 6, 2024
Dose-escalated Salvage Whole-pelvic Radiotherapy for Biochemical Recurrence After Radical Prostatectomy for High-risk Prostate Cancer
Shuhei Miyazaki, Yutaro Tasaki, Mika Nakatake, et al.
The Prostate
|
September 7, 2021
Pathological significance and prognostic role of LATS2 in prostate cancer
Tsuyoshi Matsuda, Yasuyoshi Miyata, Yuichiro Nakamura, et al.
In Vivo (Athens, Greece)
|
April 29, 2021
Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer
Junki Harada, Yasuyoshi Miyata, Kyohei Araki, et al.
International Cancer Conference Journal
|
March 25, 2024
Primary signet-ring cell carcinoma of the bladder treated with laparoscopic radical cystectomy: a case report
Yuta Mukae, Kojiro Ohba, Kyohei Araki, et al.
International Journal of Molecular Sciences
|
July 25, 2019
Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation
Mineaki Kitamura, Yasushi Mochizuki, Yasuyoshi Miyata, et al.
International Journal of Molecular Sciences
|
August 7, 2019
Periodontal Disease in Patients Receiving Dialysis
Yasuyoshi Miyata, Yoko Obata, Yasushi Mochizuki, et al.
Molecular and Clinical Oncology
|
August 9, 2020
Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
Yasuyoshi Miyata, Kyohei Araki, Kojiro Ohba, et al.
Anticancer Research
|
July 7, 2021
Stage-specific Embryogenic Antigen-4 Expression in Castration-resistant Prostate Cancer and its Correlation With the Androgen Receptor
Junki Harada, Yasuyoshi Miyata, Takenobu Taima, et al.
Anticancer Research
|
April 30, 2022
Pathological Significance and Prognostic Role of WWC1 in Upper Urinary Tract Urothelial Cancer
Hiroki Kurata, Kensuke Mitsunari, Tsubasa Kondo, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Molecular and Clinical Oncology
|
October 16, 2020
Erratum: Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
Yasuyoshi Miyata, Kyohei Araki, Kojiro Ohba, et al.
Cancer Diagnosis & Prognosis
|
May 6, 2024
Dose-escalated Salvage Whole-pelvic Radiotherapy for Biochemical Recurrence After Radical Prostatectomy for High-risk Prostate Cancer
Shuhei Miyazaki, Yutaro Tasaki, Mika Nakatake, et al.
The Prostate
|
September 7, 2021
Pathological significance and prognostic role of LATS2 in prostate cancer
Tsuyoshi Matsuda, Yasuyoshi Miyata, Yuichiro Nakamura, et al.
In Vivo (Athens, Greece)
|
April 29, 2021
Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer
Junki Harada, Yasuyoshi Miyata, Kyohei Araki, et al.
International Cancer Conference Journal
|
March 25, 2024
Primary signet-ring cell carcinoma of the bladder treated with laparoscopic radical cystectomy: a case report
Yuta Mukae, Kojiro Ohba, Kyohei Araki, et al.
International Journal of Molecular Sciences
|
July 25, 2019
Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation
Mineaki Kitamura, Yasushi Mochizuki, Yasuyoshi Miyata, et al.
International Journal of Molecular Sciences
|
August 7, 2019
Periodontal Disease in Patients Receiving Dialysis
Yasuyoshi Miyata, Yoko Obata, Yasushi Mochizuki, et al.
Molecular and Clinical Oncology
|
August 9, 2020
Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
Yasuyoshi Miyata, Kyohei Araki, Kojiro Ohba, et al.
Anticancer Research
|
July 7, 2021
Stage-specific Embryogenic Antigen-4 Expression in Castration-resistant Prostate Cancer and its Correlation With the Androgen Receptor
Junki Harada, Yasuyoshi Miyata, Takenobu Taima, et al.
Anticancer Research
|
April 30, 2022
Pathological Significance and Prognostic Role of WWC1 in Upper Urinary Tract Urothelial Cancer
Hiroki Kurata, Kensuke Mitsunari, Tsubasa Kondo, et al.
Page
of 9